BioCryst Pharmaceuticals
BCRX
BCRX
221 hedge funds and large institutions have $1.61B invested in BioCryst Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
-12
Holders Change %
-5.15%
% of All Funds
3.74%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
43
Increased
70
Reduced
61
Closed
51
Calls
$51.3M
Puts
$26.8M
Net Calls
+$24.6M
Net Calls Change
-$32.6M
